YD Bio COO Resigns for Health Reasons
Ticker: YDESW · Form: 6-K · Filed: Sep 26, 2025 · CIK: 2011674
| Field | Detail |
|---|---|
| Company | Yd Bio Ltd (YDESW) |
| Form Type | 6-K |
| Filed Date | Sep 26, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, personnel-change, health-reasons
TL;DR
YD Bio COO May Tsai out, citing health. No drama, just personal reasons.
AI Summary
YD Bio Limited announced on September 24, 2025, that its Chief Operating Officer, Ms. May Tsai, resigned due to personal health reasons. Her resignation was effective immediately on the same date and was not due to any disagreements with the company.
Why It Matters
The departure of a Chief Operating Officer can signal internal changes or challenges within a company, potentially impacting operational continuity and future strategy.
Risk Assessment
Risk Level: medium — The unexpected departure of a key executive like the COO can introduce uncertainty regarding leadership stability and operational execution.
Key Players & Entities
- YD Bio Limited (company) — The company filing the report
- May Tsai (person) — Chief Operating Officer who resigned
- September 24, 2025 (date) — Date of resignation and effective date
FAQ
Who is YD Bio Limited?
YD Bio Limited is a foreign private issuer that files reports with the SEC, with its principal executive office located in Taipei, Taiwan.
What is the purpose of this 6-K filing?
This 6-K filing is a Report of Foreign Private Issuer for the month of September 2025, specifically announcing the departure of the Chief Operating Officer.
When did Ms. May Tsai's resignation become effective?
Ms. May Tsai's resignation as Chief Operating Officer was effective as of September 24, 2025.
What reason was given for Ms. Tsai's resignation?
Ms. Tsai resigned for personal health reasons.
Were there any disagreements leading to Ms. Tsai's departure?
No, the filing explicitly states that Ms. Tsai's resignation was not the result of any disagreement with the Company on any matter.
Filing Stats: 466 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2025-09-26 08:30:12
Filing Documents
- ea0258907-6k_ydbio.htm (6-K) — 11KB
- 0001213900-25-091940.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. YD Bio Limited By: /s/ Ethan Shen Name: Ethan Shen Title: Chief Executive Officer and Chairman Date: September 26, 2025 2